Drug intelligence / Profile preview

Qingshu-Yiqi-Tang

Development stage
Phase 3
Lead developer
Chang Gung Memorial Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Qingshu-Yiqi-Tang is an Astragalus-based traditional Chinese medicine (TCM) herbal formula being developed by Chang Gung Memorial Hospital in Taiwan. It is currently being evaluated as an adjunct therapy for patients with advanced non-small cell lung cancer (NSCLC) who are receiving standard first-line doublet chemotherapy (such as cisplatin plus docetaxel or pemetrexed) and second-line targeted therapy (erlotinib). The formula is designed to modulate the immune system and reverse the immunosuppressive tumor microenvironment. Its primary mechanism involves targeting myeloid-derived suppressor cells (MDSCs) and regulatory T cells to prevent cytotoxic T cell apoptosis and restore anti-tumor immune functions, including natural killer (NK) cell activity and Th1 cell responses.

Other names
Qingshu Yiqi TangAstragalus-based formula
02

Targets

CHRM2 (M2)

Beyond the preview

Go deeper on Qingshu-Yiqi-Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingshu-Yiqi-Tang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call